Clinical Trial Center Maastricht

Clinical Trial Center Maastricht is a company in Maastricht, Netherlands that has taken part in 5 EU-funded projects since 2008, receiving €221k in EU funding.

EU funding received€221k
EU projects5
As coordinator0
Running now0
First EU project2008
Latest project2019
CountryNetherlands
EU registration (PIC)950144683
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Clinical Trial Center Maastricht's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€221k · 3 projects
  • Horizon 2020€0 · 2 projects

Projects

5 EU-funded projects, newest first. Each links to the official record.

  • CARDIATEAMAssociated partner

    CARdiomyopathy in type 2 DIAbetes mellitus

    Horizon 2020 · 2019–2026 · Project on CORDIS ↗

  • IMMUNOSABRAssociated partner

    Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer

    Horizon 2020 · 2017–2024 · Project on CORDIS ↗

  • BM4SITPartner

    AN INNOVATIVE CAUSAL THERAPY FOR ALLERGY: SAFE AND RAPID INDUCTION OF AN ANTI-INFLAMMATORY IMMUNE RESPONSE USING A MUTANT HYPOALLERGEN AND VITAMIN D3

    FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗

    €31ktheir share
  • ECRIN-IAPartner

    European Clinical Research Infrastructures Network - Integrating Activity

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €57ktheir share
  • FASTPartner

    TOWARDS SAFE AND EFFECTIVE IMMUNOTHERAPY OF PERSISTENT LIFE-THREATENING FOOD ALLERGIES

    FP7 (2007 to 2013) · 2008–2017 · Project on CORDIS ↗

    €133ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • allergology
  • databases
  • diabetes
  • food allergy
  • fruit growing
  • immunotherapy
  • inflammatory diseases
  • lung cancer
  • mutation
  • nutrition
  • pathophysiology
  • pharmaceutical drugs
  • toxicology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime